These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 35443818)

  • 21. The Accuracy of Single MicroRNAs in Peripheral Blood to Diagnose Ovarian Cancer: An Updated Meta-Analysis.
    Cui Y; Hong S; Zhu X
    Dis Markers; 2020; 2020():1075942. PubMed ID: 32025275
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNAs as novel biomarkers in the diagnosis of non-small cell lung cancer: a meta-analysis based on 20 studies.
    Chen L; Jin H
    Tumour Biol; 2014 Sep; 35(9):9119-29. PubMed ID: 25027397
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma microRNA Profile Differentiates Crohn's Colitis From Ulcerative Colitis.
    Netz U; Carter J; Eichenberger MR; Feagins K; Galbraith NJ; Dryden GW; Pan J; Rai SN; Galandiuk S
    Inflamm Bowel Dis; 2017 Dec; 24(1):159-165. PubMed ID: 29272478
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Accuracy of Ultrasound for Evaluation of Colorectal Segments in Patients With Inflammatory Bowel Diseases: A Systematic Review and Meta-analysis.
    Sagami S; Kobayashi T; Miyatani Y; Okabayashi S; Yamazaki H; Takada T; Kinoshita K; Allocca M; Kunisaki R; Ramaswamy PK; Shiraki M; Hibi T; Kataoka Y
    Clin Gastroenterol Hepatol; 2021 May; 19(5):908-921.e6. PubMed ID: 32777549
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating and Fecal microRNAs as Biomarkers for Inflammatory Bowel Diseases.
    Schönauen K; Le N; von Arnim U; Schulz C; Malfertheiner P; Link A
    Inflamm Bowel Dis; 2018 Jun; 24(7):1547-1557. PubMed ID: 29668922
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of serological markers of inflammatory bowel disease with clinical diagnosis in children.
    Gupta SK; Fitzgerald JF; Croffie JM; Pfefferkorn MD; Molleston JP; Corkins MR
    Inflamm Bowel Dis; 2004 May; 10(3):240-4. PubMed ID: 15290918
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating microRNA-21 as a biomarker for the detection of various carcinomas: an updated meta-analysis based on 36 studies.
    Wu K; Li L; Li S
    Tumour Biol; 2015 Mar; 36(3):1973-81. PubMed ID: 25527152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating miRNA-16 in inflammatory bowel disease and some clinical correlations - a cohort study in Bulgarian patients.
    Atanassova A; Georgieva A
    Eur Rev Med Pharmacol Sci; 2022 Sep; 26(17):6310-6315. PubMed ID: 36111932
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exploring potential biomarkers and therapeutic targets in inflammatory bowel disease: insights from a mega-analysis approach.
    Stemmer E; Zahavi T; Kellerman M; Sinberger LA; Shrem G; Salmon-Divon M
    Front Immunol; 2024; 15():1353402. PubMed ID: 38510241
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNAs in Parkinson's disease: a systematic review and diagnostic accuracy meta-analysis.
    Guévremont D; Roy J; Cutfield NJ; Williams JM
    Sci Rep; 2023 Sep; 13(1):16272. PubMed ID: 37770507
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNAs in Inflammatory Bowel Disease and Its Complications.
    Krishnachaitanya SS; Liu M; Fujise K; Li Q
    Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR-20b, miR-98, miR-125b-1*, and let-7e* as new potential diagnostic biomarkers in ulcerative colitis.
    Coskun M; Bjerrum JT; Seidelin JB; Troelsen JT; Olsen J; Nielsen OH
    World J Gastroenterol; 2013 Jul; 19(27):4289-99. PubMed ID: 23885139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A panel of circulating miRNAs as diagnostic biomarkers for screening multiple myeloma: a systematic review and meta-analysis.
    Zhang L; Cao D; Tang L; Sun C; Hu Y
    Int J Lab Hematol; 2016 Dec; 38(6):589-599. PubMed ID: 27870469
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNAs as potential biomarkers for the diagnosis of glioma: A systematic review and meta-analysis.
    Zhou Q; Liu J; Quan J; Liu W; Tan H; Li W
    Cancer Sci; 2018 Sep; 109(9):2651-2659. PubMed ID: 29949235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic value of circulating microRNAs in thyroid carcinoma: A systematic review and meta-analysis.
    Xu SL; Tian YY; Zhou Y; Liu LQ
    Clin Endocrinol (Oxf); 2020 Oct; 93(4):489-498. PubMed ID: 32379941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum immunoinflammation-related protein complexes discriminate between inflammatory bowel disease and colorectal cancer.
    Sun YH; Li J; Shu HJ; Li ZL; Qian JM
    Clin Transl Oncol; 2019 Dec; 21(12):1680-1686. PubMed ID: 30955196
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnosing Inflammatory bowel disease using noninvasive applications of volatile organic compounds: a systematic review.
    Bannaga AS; Farrugia A; Arasaradnam RP
    Expert Rev Gastroenterol Hepatol; 2019 Nov; 13(11):1113-1122. PubMed ID: 31657950
    [No Abstract]   [Full Text] [Related]  

  • 38. miRNA Molecules-Late Breaking Treatment for Inflammatory Bowel Diseases?
    Aggeletopoulou I; Mouzaki A; Thomopoulos K; Triantos C
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768556
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of Primary Sclerosing Cholangitis in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
    Barberio B; Massimi D; Cazzagon N; Zingone F; Ford AC; Savarino EV
    Gastroenterology; 2021 Dec; 161(6):1865-1877. PubMed ID: 34425093
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of miRNAs as potential new biomarkers for nervous system cancer.
    Wang Y; Liang J; Di C; Zhao G; Zhao Y
    Tumour Biol; 2014 Nov; 35(11):11631-8. PubMed ID: 25139093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.